Bottomline: Warburg-backed Micro Life’s revenue, profit jump but patent feud weighs
Advertisement

Bottomline: Warburg-backed Micro Life’s revenue, profit jump but patent feud weighs

By Priyal Mahtta

  • 27 Sep 2023
Premium
Bottomline: Warburg-backed Micro Life’s revenue, profit jump but patent feud weighs
Credit: Pixabay

Medical devices maker Micro Life Sciences Pvt Ltd recorded a significant jump in its revenue and profit for the financial year through March 2023 but a patent battle and high capital expenditure weigh on its outlook.   The company, which is backed by private equity firm Warburg Pincus, posted a 41% rise ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement